51. Macrophage migration inhibitory factor induces contractile and mitochondria dysfunction by altering cytoskeleton network in the human heart.
- Author
-
Preau S, Montaigne D, Modine T, Fayad G, Koussa M, Tardivel M, Durocher A, Saulnier F, Marechal X, and Neviere R
- Subjects
- AMP-Activated Protein Kinases antagonists & inhibitors, Colchicine pharmacology, Cytoskeleton metabolism, Humans, In Vitro Techniques, Lactic Acid metabolism, Mitochondria, Heart metabolism, Muscle Contraction, Myocytes, Cardiac metabolism, Nitrates metabolism, Nitrites metabolism, Paclitaxel pharmacology, Pyrazoles pharmacology, Pyrimidines pharmacology, Troponin I metabolism, Tubulin Modulators pharmacology, Tumor Necrosis Factor-alpha metabolism, Cytoskeleton drug effects, Macrophage Migration-Inhibitory Factors pharmacology, Mitochondria, Heart drug effects, Myocardium metabolism, Myocytes, Cardiac drug effects
- Abstract
Objectives: Macrophage migration inhibitory factor (MIF) has been recognized as a potent proinflammatory mediator that may induce myocardial dysfunction. Mechanisms by which MIF affects cardiac function are not completely elucidated; yet, some macrophage migration inhibitory effects have been related to changes in cytoskeleton architecture. We hypothesized that MIF-induced myocardial dysfunction and mitochondrial respiration deficit could be related to cardiac cell microtubule dynamics alterations., Design: Prospective, randomized study., Setting: Experimental Cardiovascular Laboratory, University Hospital., Subjects: Human myocardial (atrial) trabeculae., Interventions: Atrial trabeculae were obtained at the time of cardiac surgery. Isometrically contracting isolated human right atrial trabeculae were exposed to MIF (100 ng/mL) for 60 minutes, in the presence or not of pretreatment with colchicine (10 µM), a microtubule-depolymerizing agent, or paclitaxel (10 µM) a microtubule-stabilizing agent., Measurements and Main Results: Maximal active isometric tension curve and developed isometric force were studied. Trabeculae were then permeabilized for mitochondrial respiration studies using high-resolution oxygraphy. Heart fiber electron microscopy and visualization of βIV tubulin and polymerized actin by confocal microscopy were used to evaluate sarcomere and microtubule disarray. Compared with controls, MIF elicited cardiac contractile and mitochondrial dysfunction, which were largely prevented by pretreatment with colchicine, but not by paclitaxel. Pretreatment with colchicine prevented MIF-induced microtubule network disorganization, excessive tubulin polymerization, and mitochondrial fragmentation. Compound-C, an inhibitor of AMP-activated protein kinase (AMPK), partially prevented contractile dysfunction, suggesting that cardiac deleterious effects of MIF were related to AMPK activation., Conclusions: MIF depresses human myocardial contractile function and impairs mitochondrial respiration. Changes in microtubule network likely promote MIF-induced cardiac dysfunction by 1) altering with mitochondrial tubular assembly and outer membrane permeability for adenine nucleotides leading to energy deficit, 2) excessive tubulin polymerization that may impede cardiomyocyte viscosity and motion, and 3) interfering with AMPK pathway.
- Published
- 2013
- Full Text
- View/download PDF